Femme et Homme
- | Pays :
- United States
- Croatia
- Latvia
- | Organes : -
- | Spécialités : -
Extrait
The primary purpose of this study is to evaluate the overall efficacy of aripiprazole intramuscular (IM) depot as acute treatment in subjects with schizophrenia. The secondary purpose is to evaluate the safety and tolerability of aripiprazole IM depot administered every 4 weeks for 12 weeks to adult subjects with schizophrenia.
Critère d'inclusion
- Schizophrenia